In addition to the risk that children with CPP will not reach their adult height potential, a range of studies have noted a high risk for psychological, social, and behavioral problems in this population.
Women with infertility-treated pregnancy have an increased risk for severe maternal morbidity or maternal death, with invasive infertility treatment associated with an increased likelihood of having three or more severe maternal morbidity indicators.
Children born by medically assisted reproduction have an increased risk for adverse birth outcomes; however, the increased risk appears to be attributable to other factors.
The expanded approval was based on safety and efficacy data from a confirmatory Phase 3 randomized, double-blind, placebo-controlled multicenter study evaluating Osphena in patients with moderate to severe vaginal dryness.
Initiation and continuation trends in menopausal hormone therapy may have been influenced by the premature cessation of the 2002 Women’s Health Initiative trial, which was halted due to safety concerns.
For women undergoing in vitro fertilization (IVF), endometrial scratching by pipelle biopsy between day 3 of the cycle preceding the embryo-transfer cycle and day 3 of the embryo-transfer cycle, does not result in a higher rate of live birth.
Researchers sought to determine whether behavioral modification intervention could help improve reproductive function in women with obesity with polycystic ovary syndrome even when their weight loss is minimum.
